Clinical Trials
임상시험 트래커
국내사는 전체 임상 이력, 글로벌 메이저는 진행 중 파이프라인을 추적합니다. ClinicalTrials.gov API v2에서 6시간 주기로 수집합니다.
기업
19 results
- 2상모집 중· Generalized Myasthenia Gravis소아 일반화 근무력증 환자에서 이네빌리주맙의 약동학, 약력학, 안전성 및 내약성 평가 연구
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)
리드: 암젠
- 2상모집 중· Thyroid Eye Disease갑상선 안구 질환이 있는 참가자에서 AMG 732의 효과 및 안전성을 평가하는 공개 롤오버 시험
An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease
리드: 암젠
- 2상모집 중· Extensive Stage Lung Small Cell Cancer전처치 광범위 소세포폐암 및 ECOG 수행도 2인 환자에서의 타를라타맙 임상시험
A Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2
협력: 암젠
- 2상모집 중· Extensive Stage Lung Small Cell CarcinomaTarlatamab for the Treatment of Extensive Stage Small-cell Lung Cancer
협력: 암젠
- 2상모집 중· Overweight or Obesity and Elevated Liver FatA Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight
리드: 암젠
- 2상모집 중· Advanced Solid TumorsA Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C Mutation
리드: 암젠
- 2상모집 중· Extrapulmonary Small Cell Carcinoma and Neuroendocrine CarcinomaTarlatamab for Advanced Extrapulmonary Small Cell Carcinoma and Neuroendocrine Carcinoma (TAURUS)
협력: 암젠
- 2상모집 중· Systemic Lupus ErythematosusA Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
리드: 암젠
- 2상모집 중· Metastatic/Locally Advanced Small-Cell Lung CancerStudy Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and Other Poorly Differentiated Neuroendocrine Carcinomas (NECs), With Biomarker Analysis to Characterize Response/Resistance (UNLOCK TARLATAMAB)
협력: 암젠
- 2상모집 중· Acute Lymphoblastic LeukemiaTherapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
협력: 암젠, 화이자
- 2상모집 중· Neuromyelitis Optica Spectrum DisorderStudy of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
리드: 암젠
- 2상모집 중· Multiple MyelomaStudy of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma
협력: 암젠, GSK
- 2상모집 중· B-cell Acute Lymphoblastic LeukemiaBlinatumomab After TCR Alpha Beta/CD19 Depleted HCT
협력: 암젠
- 2상모집 중· Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveBlinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia
협력: 암젠, 다케다
- 2상모집 중· CancerThe Drug Rediscovery Protocol (DRUP Trial)
협력: 암젠, 아스트라제네카, BMS, GSK, 일라이 릴리, 머크(MSD), 노바티스, 화이자
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.